Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126232493 | 12623249 | 3 | F | 20160628 | 20160906 | 20160804 | 20160912 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062367 | BRISTOL MYERS SQUIBB | 86.12 | YR | F | Y | 0.00000 | 20160912 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126232493 | 12623249 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, QD | Y | 202155 | 2.5 | MG | FILM-COATED TABLET | QD | |||||
| 126232493 | 12623249 | 2 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, QD | Y | 0 | 200 | MG | TABLET | QD | |||||
| 126232493 | 12623249 | 3 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Y | 0 | TABLET | ||||||||||
| 126232493 | 12623249 | 4 | SS | ATROVENT | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 0.5 MG, TID | Y | 0 | .5 | MG | TID | ||||||
| 126232493 | 12623249 | 5 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 1.25 MG, QD | U | 0 | 1.25 | MG | QD | ||||||
| 126232493 | 12623249 | 6 | C | ALDACTAZINE | ALTHIAZIDESPIRONOLACTONE | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 126232493 | 12623249 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 20 MG, QD | Y | 0 | 20 | MG | QD | ||||||
| 126232493 | 12623249 | 8 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 1 DF:250 ?G/25 ?G , BID | U | 0 | 1 | DF | BID | ||||||
| 126232493 | 12623249 | 9 | C | BRICANYL | TERBUTALINE SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 126232493 | 12623249 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126232493 | 12623249 | 1 | Cerebrovascular accident prophylaxis |
| 126232493 | 12623249 | 2 | Arrhythmia |
| 126232493 | 12623249 | 3 | Atrial fibrillation |
| 126232493 | 12623249 | 4 | Product used for unknown indication |
| 126232493 | 12623249 | 5 | Hypertension |
| 126232493 | 12623249 | 6 | Product used for unknown indication |
| 126232493 | 12623249 | 7 | Product used for unknown indication |
| 126232493 | 12623249 | 8 | Product used for unknown indication |
| 126232493 | 12623249 | 9 | Product used for unknown indication |
| 126232493 | 12623249 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126232493 | 12623249 | HO |
| 126232493 | 12623249 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126232493 | 12623249 | Blood alkaline phosphatase increased | |
| 126232493 | 12623249 | Dyspnoea | |
| 126232493 | 12623249 | Gamma-glutamyltransferase increased | |
| 126232493 | 12623249 | Liver injury | |
| 126232493 | 12623249 | Prescribed underdose | |
| 126232493 | 12623249 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126232493 | 12623249 | 1 | 201605 | 20160629 | 0 | |
| 126232493 | 12623249 | 2 | 201605 | 20160629 | 0 | |
| 126232493 | 12623249 | 4 | 201605 | 20160629 | 0 |